Cabaletta Bio, Inc. Profile Avatar - Palmy Investing

Cabaletta Bio, Inc.

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor…

Biotechnology
US, Philadelphia [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of CABA's Analysis
CIK: 1759138 CUSIP: 12674W109 ISIN: US12674W1099 LEI: - UEI: -
Secondary Listings
CABA has no secondary listings inside our databases.